--2024/Q4-- / 3.150M--
--2024/Q3-- / 2.625M--
Aug 13, 20242024/Q22.400M / 3.155M--
May 9, 20242024/Q12.631M / 3.280M--
Mar 26, 20242023/Q43.727M / 3.400M--
US Stock MarketDetailed Quotes
NBY NovaBay Pharmaceuticals
- 0.4801
- +0.0082+1.74%
Trading Sep 13 14:45 ET
2.35MMarket Cap-7P/E (TTM)
0.4998High0.4750Low72.70KVolume0.4760Open0.4719Pre Close35.41KTurnover1.49%Turnover RatioLossP/E (Static)4.89MShares17.738052wk High-3.75P/B2.34MFloat Cap0.361152wk Low--Dividend TTM4.88MShs Float130156.1979Historical High--Div YieldTTM5.26%Amplitude0.3610Historical Low0.4870Avg Price1Lot Size
NovaBay Pharmaceuticals Key Stats
NovaBay Pharmaceuticals Q2 2024 Earnings Date
Currency：USDAug 13, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 3.16M | 2.40M | -755.00K |
| Miss Est. | -31.56% | -32.09% | -23.93% |
| EPS | -1.22 | -1.37 | -0.15 |
| Miss Est. | +97.24% | +96.92% | -11.85% |
Analyst Rating
No Data
NovaBay Pharmaceuticals Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
NovaBay Pharmaceuticals Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data